-
Loading metrics
Open Access
Peer-reviewed
Research Article
Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer
-
Zhexu Dong ,
Contributed equally to this work with: Zhexu Dong, Lei Dai
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Lei Dai ,
Contributed equally to this work with: Zhexu Dong, Lei Dai
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Resources, Writing – review & editing
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yong Zhang,
Roles Data curation, Formal analysis, Investigation, Resources, Software, Visualization, Writing – review & editing
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Chao Fang,
Roles Resources
Affiliation Department of Gastrointestinal Surgery, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Gang Shi,
Roles Data curation, Methodology, Supervision, Writing – review & editing
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Ye Chen,
Roles Resources
Affiliation Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Junshu Li,
Roles Validation
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Qin Wang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Jiamei Fu,
Roles Validation
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yan Yu,
Roles Validation
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Wenshuang Wang,
Roles Validation
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Lin Cheng,
Roles Supervision
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yi Liu,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yi Lin,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yuan Wang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Qingnan Wang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Huiling Wang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Hantao Zhang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Yujing Zhang,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Xiaolan Su,
Roles Methodology
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Shuang Zhang,
Roles Supervision
Affiliation Department of biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Feng Wang,
Roles Resources
Affiliations Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, the People’s Republic of China, Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Meng Qiu,
Roles Resources
Affiliation Department of Medical Oncology, Cancer Center, the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
⨯ -
Zongguang Zhou,
Roles Resources
Affiliation Department of Gastrointestinal Surgery, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, the People’s Republic of China
⨯ - [ ... ],
-
Hongxin Deng
Roles Conceptualization, Data curation, Funding acquisition, Methodology, Writing – review & editing
* E-mail: denghongx@scu.edu.cn
Affiliation State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan, the People’s Republic of China
⨯ - [ view all ]
- [ view less ]
Hypomethylation of GDNF family receptor alpha 1 promotes epithelial-mesenchymal transition and predicts metastasis of colorectal cancer
- Zhexu Dong,
- Lei Dai,
- Yong Zhang,
- Chao Fang,
- Gang Shi,
- Ye Chen,
- Junshu Li,
- Qin Wang,
- Jiamei Fu,
- Yan Yu
-
- Published: November 11, 2020
- https://doi.org/10.1371/journal.pgen.1009159